Gateway Investment Advisers LLC lessened its position in MetLife, Inc. (NYSE:MET – Free Report) by 6.1% during the 4th quarter, HoldingsChannel.com reports. The fund owned 2,862 shares of the financial services provider’s stock after selling 187 shares during the quarter. Gateway Investment Advisers LLC’s holdings in MetLife were worth $234,000 at the end of the most recent reporting period.
A number of other institutional investors have also recently made changes to their positions in MET. MeadowBrook Investment Advisors LLC boosted its stake in MetLife by 244.4% during the 3rd quarter. MeadowBrook Investment Advisors LLC now owns 310 shares of the financial services provider’s stock worth $26,000 after purchasing an additional 220 shares during the last quarter. Carmichael Hill & Associates Inc. lifted its stake in shares of MetLife by 131.9% in the third quarter. Carmichael Hill & Associates Inc. now owns 327 shares of the financial services provider’s stock worth $27,000 after buying an additional 186 shares in the last quarter. Wolff Wiese Magana LLC boosted its position in MetLife by 374.3% during the third quarter. Wolff Wiese Magana LLC now owns 351 shares of the financial services provider’s stock worth $29,000 after acquiring an additional 277 shares during the last quarter. Peterson Financial Group Inc. purchased a new stake in MetLife during the 3rd quarter valued at about $30,000. Finally, Fortitude Family Office LLC raised its holdings in MetLife by 177.3% in the 3rd quarter. Fortitude Family Office LLC now owns 416 shares of the financial services provider’s stock valued at $34,000 after acquiring an additional 266 shares during the last quarter. 94.99% of the stock is owned by institutional investors and hedge funds.
Analyst Upgrades and Downgrades
MET has been the topic of several recent research reports. Wells Fargo & Company lowered their target price on MetLife from $93.00 to $92.00 and set an “overweight” rating on the stock in a report on Tuesday, January 14th. StockNews.com lowered MetLife from a “buy” rating to a “hold” rating in a research note on Thursday, January 9th. TD Cowen raised their target price on MetLife from $97.00 to $99.00 and gave the stock a “buy” rating in a research note on Wednesday, November 27th. Barclays boosted their price target on shares of MetLife from $90.00 to $96.00 and gave the company an “overweight” rating in a research report on Monday, January 6th. Finally, Piper Sandler raised their price objective on shares of MetLife from $85.00 to $92.00 and gave the stock an “overweight” rating in a research report on Wednesday, October 2nd. One research analyst has rated the stock with a hold rating and twelve have assigned a buy rating to the company. Based on data from MarketBeat, MetLife presently has a consensus rating of “Moderate Buy” and a consensus price target of $89.92.
MetLife Stock Up 1.1 %
MetLife stock opened at $86.83 on Monday. The company has a market capitalization of $60.12 billion, a PE ratio of 17.51, a price-to-earnings-growth ratio of 0.59 and a beta of 1.07. The company has a debt-to-equity ratio of 0.51, a quick ratio of 0.16 and a current ratio of 0.16. MetLife, Inc. has a fifty-two week low of $64.61 and a fifty-two week high of $89.05. The firm has a 50 day moving average price of $83.41 and a 200 day moving average price of $79.47.
MetLife Announces Dividend
The company also recently disclosed a quarterly dividend, which will be paid on Tuesday, March 11th. Stockholders of record on Tuesday, February 4th will be paid a $0.545 dividend. The ex-dividend date is Tuesday, February 4th. This represents a $2.18 dividend on an annualized basis and a dividend yield of 2.51%. MetLife’s payout ratio is presently 43.95%.
MetLife Company Profile
MetLife, Inc, a financial services company, provides insurance, annuities, employee benefits, and asset management services worldwide. It operates through six segments: Retirement and Income Solutions; Group Benefits; Asia; Latin America; Europe, the Middle East and Africa; and MetLife Holdings. The company offers life, dental, group short-and long-term disability, individual disability, pet insurance, accidental death and dismemberment, vision, and accident and health coverages, as well as prepaid legal plans; administrative services-only arrangements to employers; and general and separate account, and synthetic guaranteed interest contracts, as well as private floating rate funding agreements.
Featured Articles
- Five stocks we like better than MetLife
- Compound Interest and Why It Matters When Investing
- Earn High Dividends With 2 Top REITs Set to Perform in 2025
- How to Capture the Benefits of Dividend Increases
- Oilfield Leader SLB: An AI Name You Need to Know
- How to Invest in the FAANG Stocks
- Top ETFs That Beat the Market in 2024 and Could Do It Again
Want to see what other hedge funds are holding MET? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for MetLife, Inc. (NYSE:MET – Free Report).
Receive News & Ratings for MetLife Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for MetLife and related companies with MarketBeat.com's FREE daily email newsletter.